News

Smart for Life Enters into New Distribution Agreement with BOXOUT®, to Expand Distribution of Greens First Product LineSmart for Life Enters into New Distribution Agreement with BOXOUT®, to Expand Distribution of Greens First Product Line

Smart for Life Enters into New Distribution Agreement with BOXOUT®, to Expand Distribution of Greens First Product Line

Launches New E-commerce Initiatives with BoxoutMIAMI, March 23, 2023 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for…

2 years ago
Healthcare Triangle to Participate in ViVE 2023 as Presenter and SponsorHealthcare Triangle to Participate in ViVE 2023 as Presenter and Sponsor

Healthcare Triangle to Participate in ViVE 2023 as Presenter and Sponsor

Company to host a “Tech Talk” featuring client CalvertHealth on March 27thPLEASANTON, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Healthcare…

2 years ago
Lisata Therapeutics to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, March 30, 2023, at 4:30 p.m. Eastern TimeLisata Therapeutics to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, March 30, 2023, at 4:30 p.m. Eastern Time

Lisata Therapeutics to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, March 30, 2023, at 4:30 p.m. Eastern Time

BASKING RIDGE, N.J., March 23, 2023 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage…

2 years ago
New Study Confirms Daxor’s BVA-100® Volume Metric Compared to CardioMEMS® Pressure Metric Has Unique Clinical Utility as a Diagnostic for Heart Failure PatientsNew Study Confirms Daxor’s BVA-100® Volume Metric Compared to CardioMEMS® Pressure Metric Has Unique Clinical Utility as a Diagnostic for Heart Failure Patients

New Study Confirms Daxor’s BVA-100® Volume Metric Compared to CardioMEMS® Pressure Metric Has Unique Clinical Utility as a Diagnostic for Heart Failure Patients

Commonly Used Pressure Measure for Volume Assessment Discordant with Direct Measurement by BVA Oak Ridge, TN, March 23, 2023 (GLOBE…

2 years ago
Aeterna Zentaris Reports Fourth Quarter and Full Year 2022 Financial ResultsAeterna Zentaris Reports Fourth Quarter and Full Year 2022 Financial Results

Aeterna Zentaris Reports Fourth Quarter and Full Year 2022 Financial Results

– Company ended the year with $50.6 million in cash, expected to fund operations through 2024 and into 2025– Executing…

2 years ago
Palisade Bio Reports Year End 2022 Financial Results and Provides Corporate UpdatePalisade Bio Reports Year End 2022 Financial Results and Provides Corporate Update

Palisade Bio Reports Year End 2022 Financial Results and Provides Corporate Update

Phase 2 topline data readout for prevention of post-surgical abdominal adhesions on track for Q2 2023 Strong balance sheet with…

2 years ago
Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2022 ResultsLandos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2022 Results

Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2022 Results

On Track to Initiate Phase 2 Proof-of-Concept Trial in Ulcerative Colitis for NX-13 in the Second Quarter of 2023 and…

2 years ago
Biomea Fusion to Host Conference Call and Webcast to Discuss Initial Phase II Clinical Data for BMF-219 in Subjects with Type 2 Diabetes on March 28th, 2023 at 8:30 a.m. ETBiomea Fusion to Host Conference Call and Webcast to Discuss Initial Phase II Clinical Data for BMF-219 in Subjects with Type 2 Diabetes on March 28th, 2023 at 8:30 a.m. ET

Biomea Fusion to Host Conference Call and Webcast to Discuss Initial Phase II Clinical Data for BMF-219 in Subjects with Type 2 Diabetes on March 28th, 2023 at 8:30 a.m. ET

REDWOOD CITY, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated…

2 years ago
Daré Bioscience to Host Full-year 2022 Financial Results and Company Update Conference Call and Webcast on March 30, 2023Daré Bioscience to Host Full-year 2022 Financial Results and Company Update Conference Call and Webcast on March 30, 2023

Daré Bioscience to Host Full-year 2022 Financial Results and Company Update Conference Call and Webcast on March 30, 2023

SAN DIEGO, March 23, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today…

2 years ago